Педиатрическая фармакология (Oct 2022)

Modern Approaches to the Management of Children with Mucopolysaccharidosis Type I

  • Galina V. Baidakova,
  • Alexander A. Baranov,
  • Irina V. Vakhlova,
  • Nato D. Vashakmadze,
  • Elena Yu. Voskoboeva,
  • Ekaterina Yu. Zakharova,
  • Ludmila M. Kuzenkova,
  • Sergey I. Kutsev,
  • Valentina I. Larionova,
  • Tina V. Lobzhanidze,
  • Ludmila K. Mikhailova,
  • Svetlana V. Mikhailova,
  • Sergey V. Moiseev,
  • Leyla S. Namazova-Baranova,
  • Sergey S. Nikitin,
  • Natalya L. Pechatnikova,
  • Olga A. Polyakova,
  • Alla N. Semyachkina,
  • Olga V. Udalova

DOI
https://doi.org/10.15690/pf.v19i4.2443
Journal volume & issue
Vol. 19, no. 4
pp. 342 – 353

Abstract

Read online

This article presents modern data on epidemiology, etiology, and clinical manifestations of mucopolysaccharidosis (MPS) type I in children. MPS develops due to deficiency of particular lysosomal enzyme which determines the disease type. The article considers in details disease's pathogenesis and classification. Evidence-based approaches to diagnosis (differential diagnosis included) are covered, moreover, special attention is paid to pathogenetic, symptomatic, and surgical treatment of MPS.

Keywords